期刊
IMMUNOLOGICAL REVIEWS
卷 291, 期 1, 页码 174-189出版社
WILEY
DOI: 10.1111/imr.12791
关键词
B-cell lymphoproliferation; cell-cytotoxicity; Epstein-Barr virus; hemophagocytic lymphohistiocytosis; primary immunodeficiency; T-cell proliferation
类别
资金
- Ligue Contre le Cancer-Equipe Labellisee
- INSERM
- ANR [ANR-18-CE15-0025-01]
- Fondation Maladies Rares
- Societe Francaise de lutte contre les Cancers et les leucemies de l'Enfant et de l'Adolescent/SFCE
- European Research Council [ERC-2009-AdG_ 20090506, FP7-249816]
- College de France
- Agence Nationale de la Recherche (ANR) [ANR-18-CE15-0025] Funding Source: Agence Nationale de la Recherche (ANR)
Primary immunodeficiencies (PIDs) provide researchers with unique models to understand in vivo immune responses in general and immunity to infections in particular. In humans, impaired immune control of Epstein-Barr virus (EBV) infection is associated with the occurrence of several different immunopathologic conditions; these include non-malignant and malignant B-cell lymphoproliferative disorders, hemophagocytic lymphohistiocytosis (HLH), a severe inflammatory condition, and a chronic acute EBV infection of T cells. Studies of PIDs associated with a predisposition to develop severe, chronic EBV infections have led to the identification of key components of immunity to EBV - notably the central role of T-cell expansion and its regulation in the pathophysiology of EBV-associated diseases. On one hand, the defective expansion of EBV-specific CD8 T cells results from mutations in genes involved in T-cell activation (such as RASGRP1, MAGT1, and ITK), DNA metabolism (CTPS1) or co-stimulatory pathways (CD70, CD27, and TNFSFR9 (also known as CD137/4-1BB)) leads to impaired elimination of proliferating EBV-infected B cells and the occurrence of lymphoma. On the other hand, protracted T-cell expansion and activation after the defective killing of EBV-infected B cells is caused by genetic defects in the components of the lytic granule exocytosis pathway or in the small adapter protein SH2D1A (also known as SAP), a key activator of T- and NK cell-cytotoxicity. In this setting, the persistence of EBV-infected cells results in HLH, a condition characterized by unleashed T-cell and macrophage activation. Moreover, genetic defects causing selective vulnerability to EBV infection have highlighted the role of co-receptor molecules (CD27, CD137, and SLAM-R) selectively involved in immune responses against infected B cells via specific T-B cell interactions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据